---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-009501"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:22:08.512371+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics appoints Travis Thompson as CFO, succeeding Alethia Young

## Summary
- Travis Thompson appointed CFO effective Jan 29, 2026; previously SVP & Chief Accounting Officer since June 2023.
- Thompson receives $500K base salary, 50% target bonus, and 58,000 option shares under 2020 Equity Plan.
- Alethia Young steps down as CFO; remains in interim role through Apr 29, 2026, then as consultant for up to 3 years.
- Young eligible for 9 months severance, full 2025 bonus, pro-rated 2026 bonus, and 9 months COBRA.
- Thompson has no family relationships or related-party transactions with the company.

## SEC filing metadata
- accession: 0001104659-26-009501
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465926009501/0001104659-26-009501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465926009501/tm264844d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-009501
- JSON: https://secwatch.observer/filing/0001104659-26-009501.json
- Plain text: https://secwatch.observer/filing/0001104659-26-009501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.